Our Take
Makary's removal would shift FDA leadership during ongoing AI medical device approvals and digital health policy development.
Why it matters
Life sciences companies with pending FDA submissions face regulatory continuity risk. AI health startups may see approval timelines extend during leadership transition.
Do this week
Regulatory teams: contact FDA liaisons this week to confirm status of pending AI medical device applications before transition.
Trump administration targets FDA Commissioner
FDA Commissioner Marty Makary faces removal from his position according to multiple media reports (per Wall Street Journal and other outlets). The administration's plans have not been finalized and could still change.
Makary's tenure included oversight of AI medical device approvals and digital health policy frameworks. The FDA under his leadership processed applications for AI-powered diagnostic tools and therapeutic algorithms.
Regulatory continuity at risk for AI health companies
Leadership changes at FDA typically create approval delays as new commissioners establish priorities. Companies with AI medical devices in the 510(k) pathway or Pre-Submission process face timeline uncertainty.
The FDA's AI/ML-based medical device guidance, finalized under Makary, governs how companies submit algorithmic tools for approval. A new commissioner may revise these frameworks or shift enforcement priorities.
Digital health companies raised $4.2 billion in funding during Makary's tenure (per industry data), with many counting on predictable FDA pathways for market entry.
Secure regulatory guidance before transition
Companies with pending FDA submissions should confirm their application status with agency liaisons. Pre-Submission meetings scheduled for the coming months may face delays or require re-presentation to new leadership.
Legal teams should review FDA correspondence for guidance that could change under new leadership. Companies relying on specific policy interpretations should document their regulatory strategy before personnel shifts occur.